Table: Phoenixbio -9-MTH group results

PhoenixBio

14/02/2017 06:30

Feb 14 (Reuters)-  
             Phoenixbio Co., Ltd.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2016        Dec 31, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              899 mln             799 mln           1.27      
                   (+12.5 pct)                          (+4.7 pct)   
  Operating          81 mln              89 mln           203 mln    
                   (-9.3 pct)                           (+6.8 pct)   
  Recurring          72 mln              84 mln           180 mln    
                   (-14.6 pct)                          (+20.9 pct)  
  Net                67 mln              71 mln           155 mln    
                   (-5.4 pct)                           (+24.2 pct)  
  EPS               23.32 yen           28.17 yen        53.86 yen   
  EPS Diluted       23.09 yen                                        
  Ann Div                                  NIL              NIL      
  -Q2 div              NIL                 NIL                       
  -Q4 div                                  NIL              NIL      
   
  NOTE - Phoenixbio Co., Ltd..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T 
  ((Tokyo Headline News Desk +813 6441 1812))